Gilead Sciences, Inc. (GILD)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
| Previous Close | 65.68 |
| Open | 65.25 |
| Bid | 63.87 x 300 |
| Ask | 63.95 x 500 |
| Day's Range | 63.74 - 65.55 |
| 52 Week Range | 63.74 - 87.87 |
| Volume | |
| Avg. Volume | 6,914,521 |
| Market Cap | 79.66B |
| Beta (5Y Monthly) | 0.23 |
| PE Ratio (TTM) | 182.69 |
| EPS (TTM) | 0.35 |
| Earnings Date | Aug 08, 2024 |
| Forward Dividend & Yield | 3.08 (4.69%) |
| Ex-Dividend Date | Jun 14, 2024 |
| 1y Target Est | 81.29 |
ACCESSWIREGilead Sciences Partners With White House for Early Cancer Detection Program "Biden Cancer Moonshot"
NORTHAMPTON, MA / ACCESSWIRE / May 28, 2024 / Gilead Sciences: In an effort to advance access to cancer prevention and early detection among U.S. workers, the Biden Cancer Moonshot recently announced a series of actions that organizations are taking ...
Business WireGilead to Present Latest Research Across Key Liver Disease Indications at the European Association for the Study of the Liver Congress 2024
FOSTER CITY, Calif., May 22, 2024--Gilead Sciences, Inc. (Nasdaq:GILD) today announced new research to be presented at the European Association for the Study of the Liver (EASL) Congress, June 5-8, 2024 in Milan, Italy. Key findings from more than 25 abstracts will include:
ZacksHere is What to Know Beyond Why Gilead Sciences, Inc. (GILD) is a Trending Stock
Recently, Zacks.com users have been paying close attention to Gilead (GILD). This makes it worthwhile to examine what the stock has in store.
© 2024 Yahoo. All rights reserved.